Sierra Oncology, Inc.
SRRA
|
$54.99
0.04%
0.0%
|
Health Technology
(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (45.1% volume)
Earnings Calendar: 2022-08-04
Market Cap: $ 1,342,820,002
http://www.sierraoncology.com
Sec Filling | Patents | 71 employees
(CA) Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.
cancer treatment profitable
add to watch list Paper trade email alert is off
Press-releases
Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical Officer and William D. Turner as Chief Development Officer
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
VERA | $38.64 -2.23% 26K
|
Professional, Scientific, and T...
|
| O: 0.58%
H: 17.29%
C: 16.07%
DVAX | $11.575 -1.57% 48K
|
Health Technology
|
| O: -0.34%
H: 0.14%
C: -4.9%
medical therapeutics
Geron Corporation Announces Appointment of Gaurav Aggarwal, M.D., to its Board of Directors
Published: 2023-11-28 (Crawled : 21:00) - biospace.com/
UNCY | $1.07 28K
|
Professional, Scientific, and T...
|
| O: -6.96%
H: 7.9%
C: 3.35%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: -0.51%
H: 0.96%
C: 0.54%
GERN | $3.63 3.71% 1.1M
|
Health Technology
|
| O: -1.05%
H: 2.65%
C: 1.06%
corporation
Global Cancer Vaccine Industry Worth $13.4 Billion by 2030: Use of Nanosensors in Diagnosing Cancer Expected to Create Ample Opportunities for Key Players
Published: 2023-06-27 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $19.54 2.6K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
GSK | News | $40.82 -1.02% 230K
|
Health Technology
|
| O: -0.91%
H: 0.56%
C: -0.5%
MRNA | News S | $109.98 1.94% 1.3M
|
Health Technology
|
| O: 0.03%
H: 0.37%
C: 0.18%
DVAX | $11.575 -1.57% 48K
|
Health Technology
|
| O: 0.08%
H: 1.31%
C: 0.77%
vaccine expected cancer global
TScan Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-10 (Crawled : 11:00) - globenewswire.com
TCRX | News 3 d | $7.26 1.2K
|
Professional, Scientific, and T...
|
| O: 25.29%
H: 27.0%
C: 13.85%
update therapeutics financial results
Codexis Announces Appointment of Kevin Norrett as Chief Operating Officer
Published: 2022-10-03 (Crawled : 14:00) - biospace.com/
CDXS | $2.89 -0.35% 26K
|
Process Industries
|
| O: 1.32%
H: 0.33%
C: -1.14%
Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration
Published: 2022-06-17 (Crawled : 17:00) - biospace.com/
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 0.02%
H: 0.33%
C: -0.07%
drug application food submission
Momelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual Meeting
Published: 2022-05-26 (Crawled : 00:00) - biospace.com/
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
presentation phase 3
Sierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual Meeting
Published: 2022-05-12 (Crawled : 19:00) - biospace.com/
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: -0.06%
H: 0.15%
C: 0.13%
presentation phase 3
Sierra Oncology Reports First Quarter 2022 Results
Published: 2022-05-06 (Crawled : 12:00) - biospace.com/
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 0.02%
H: 0.16%
C: -0.05%
results
RayzeBio Appoints Angie You, Ph.D., to its Board of Directors
Published: 2022-04-25 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 480
|
Health Technology
|
| O: 0.27%
H: 0.0%
C: 0.0%
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 0.05%
H: 0.4%
C: 0.0%
SNY | News | $47.27 -0.88% 130K
|
Health Technology
|
| O: -2.01%
H: 0.0%
C: 0.0%
ORIC | $8.55 -2.51% 24K
|
Health Technology
|
| O: -0.8%
H: 6.15%
C: 4.55%
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
CZOO | $11.44 129.26% 4.6M
|
AMST | $3.4 70.0% 51M
|
Technology Services
BOF | $1.78 52.14% 15M
|
SYRA | $1.5 51.23% 1M
|
n/a
CSSE 4 | $0.23 51.02% 46M
|
Consumer Services
RILY | $30.87 42.13% 7.8M
|
Finance
LICN | $0.76 35.71% 6.2M
|
TROO | $1.41 29.36% 280K
|
Manufacturing
MULN | News | $3.53 29.3% 4.8M
|
Information
RBBN 4 | $3.26 26.85% 1.2M
|
Electronic Technology
Last 48 Hours Insiders Buying
MEGI | $11.91 -0.58% 33K
|
|
00:30
CTRN P 29000 | $22.57 1.53% 14K
|
Retail Trade
|
22:00
CONN | $3.7 12K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.685 6.6K
|
Utilities
|
18:30
CMTV P 700 | $16.59 1K
|
Finance and Insurance
|
18:30
FNB | $13.615 -0.11% 110K
|
Finance
|
17:30
RMCF | $3.54 350
|
Consumer Non-Durables
|
20:10